New drugs could treat resistant prostate cancers

New drugs could treat resistant prostate cancers

The drugs, called Hsp90 inhibitors, which are already in clinical trials for several types of cancer, specifically target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment, the findings showed.

(Visited 3 times, 1 visits today)
3
Like
Save

Comments

Write a comment